Concentra Group Holdings Parent, Inc. · NYSE:CON

Concentra Group Holdings Parent — J.P. Morgan Healthcare Conference 2026

11 slides from Concentra Group Holdings Parent's conference presentation, January 2026

  1. Slide 1: Concentra Investor Presentation

    Concentra Investor Presentation J.P. Morgan Healthcare Conference January 2026 ©2025 Concentra Inc. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express Concentra Group Holdings Parent, Inc.'s (“Concentra,” the “Company,” “we,” “us” or “our”) current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future e

  3. Slide 3: Concentra At-a-Glance

    Concentra At-a-Glance Concentra is the largest provider of occupational health services in the United States by number of locations1, with a mission of improving the health of America’s workforce, one patient at a time (as of KEY STATISTICS ROBUST FINANCIALS* 9/30/25) 628 413 $2.1bn $414mm Occupatio

  4. Slide 4: Strong Business Fundamentals

    Strong Business Fundamentals ▪ Largest provider of occupational health services in the U.S.1, with a differentiated value proposition ▪ Treat ~1 in every 4 injuries that occur within the U.S. workplace2 Industry Leader ▪ >10x the size of next largest pure-play occupational health competitor1 ▪ 1,000

  5. Slide 5: Financial Highlights | Q4 Visits & Next Steps

    Financial Highlights | Q4 Visits & Next Steps ▪ $2.145bn – $2.160bn Revenue and $425mm – $430mm Adjusted EBITDA1 (FY 2025 guidance) Size & Scale ▪ +13% YoY growth in Revenue and Adjusted EBITDA (YTD Sep. 2025) ▪ Mid-to-high single digit organic/semi-organic growth Growth Algorithm - (a) Low single d

  6. Slide 6: Improving the health of America's workforce, one patient at a time.

    Improving the health of America’s workforce, one patient at a time. ©2025 Concentra Inc. All rights reserved.

  7. Slide 7: Appendix

    Appendix ©2025 Concentra Inc. All rights reserved.

  8. Slide 8: Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance

    Reconciliation of 2025 Full-Year Adjusted EBITDA Guidance Range ($ in millions) Low High Net Income Attributable to the Company $156 $161 Net Income Attributable to Non-Controlling Interests 7 7 Net Income $163 $168 Loss on Early Retirement of Debt 1 1 Income Tax Expense 53 55 Interest Expense 110 1

  9. Slide 9: Reconciliation of Net Income to Adjusted EBITDA

    Reconciliation of Net Income to Adjusted EBITDA TTM Sep. 30, ($ in thousands) 2025 Revenue $2,089,378 Net Income $159,458 Income Tax Expense 54,224 Interest Expense (Income) 108,863 Loss on Early Retirement of Debt 875 Stock Compensation Expense 8,711 Depreciation and Amortization 71,136 Separation

  10. Slide 10: Reconciliation to Free Cash Flow

    Reconciliation to Free Cash Flow YTD FY 2021- TTM ($ in millions) FY 2021 FY 2022 FY 2023 FY 2024 Sep. 2025 YTD Sep. 2025 Sep. 30, 2025 Net Cash Provided by Operating Activities $291 $274 $234 $275 $161 $1,235 $254 Net Cash Used in Investing Activities $(62) $(58) $(75) $(71) $(395) $(661) $(411) Bu

  11. Slide 11: Reconciliation to Return on Invested Capital (ROIC)

    Reconciliation to Return on Invested Capital (ROIC) ($ in millions) TTM Sep. 30, 2025 Operating Income $323 (x) 1-Effective Tax Rate1 76% (i) NOPAT $244 Starting Debt $1,482 Ending Debt $1,612 (a) Average Debt $1,547 Starting Equity (BV) $283 Ending Equity (BV) $391 (b) Average Equity (BV) $337 Star

Concentra Group Holdings Parent — J.P. Morgan Healthcare Conference 2026 on 6ix